ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Trio Medicines Limited

Trio Medicines Limited is an active company incorporated on 8 November 2005 with the registered office located in Brighton, East Sussex. Trio Medicines Limited was registered 20 years ago.
Status
Active
Active since incorporation
Company No
05616306
Private limited company
Age
20 years
Incorporated 8 November 2005
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Due Soon
Dated 8 November 2024 (1 year ago)
Next confirmation dated 8 November 2025
Due by 22 November 2025 (12 days remaining)
Last change occurred 4 years ago
Accounts
Submitted
For period 1 Feb31 Jan 2024 (12 months)
Accounts type is Small
Next accounts for period 31 January 2025
Due by 31 January 2026 (2 months remaining)
Address
Pavilion View, 19 New Road
Brighton
East Sussex
BN1 1EY
Same address since incorporation
Telephone
020 89614130
Email
Unreported
People
Officers
3
Shareholders
1
Controllers (PSC)
1
Director • British • Lives in England • Born in Aug 1947
Director • British • Lives in England • Born in Jul 1939
Secretary • British
Hammersmith Medicines Research Limited
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Hammersmith Medicines Research Limited
Charles Kevin O'Brien, Dr Malcolm James Boyce, and 1 more are mutual people.
Active
Human Medicines Research Limited
Charles Kevin O'Brien and Dr Malcolm James Boyce are mutual people.
Active
HMR Limited
Charles Kevin O'Brien and Dr Malcolm James Boyce are mutual people.
Active
Hammersmith Medicines Research (Properties) Limited
Dr Malcolm James Boyce is a mutual person.
Active
Brands
Trio Medicines
Trio Medicines is a pharmaceutical and biotechnology company that develops medicines for diseases with an unmet medical need.
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Jan 2024
For period 31 Jan31 Jan 2024
Traded for 12 months
Cash in Bank
£21K
Decreased by £97K (-82%)
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£123K
Decreased by £166K (-57%)
Total Liabilities
-£2.07M
Increased by £666K (+47%)
Net Assets
-£1.95M
Decreased by £832K (+74%)
Debt Ratio (%)
1685%
Increased by 1198.51% (+246%)
Latest Activity
Small Accounts Submitted
5 Months Ago on 21 May 2025
Charles Kevin O'brien Resigned
9 Months Ago on 31 Jan 2025
Confirmation Submitted
12 Months Ago on 11 Nov 2024
Small Accounts Submitted
1 Year 6 Months Ago on 24 Apr 2024
Confirmation Submitted
2 Years Ago on 9 Nov 2023
Small Accounts Submitted
2 Years 6 Months Ago on 24 Apr 2023
Compulsory Strike-Off Discontinued
2 Years 6 Months Ago on 19 Apr 2023
Compulsory Gazette Notice
2 Years 7 Months Ago on 4 Apr 2023
Confirmation Submitted
2 Years 11 Months Ago on 22 Nov 2022
Small Accounts Submitted
3 Years Ago on 1 Feb 2022
Get Credit Report
Discover Trio Medicines Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Accounts for a small company made up to 31 January 2024
Submitted on 21 May 2025
Termination of appointment of Charles Kevin O'brien as a secretary on 31 January 2025
Submitted on 3 Feb 2025
Confirmation statement made on 8 November 2024 with no updates
Submitted on 11 Nov 2024
Accounts for a small company made up to 31 January 2023
Submitted on 24 Apr 2024
Confirmation statement made on 8 November 2023 with no updates
Submitted on 9 Nov 2023
Accounts for a small company made up to 31 January 2022
Submitted on 24 Apr 2023
Compulsory strike-off action has been discontinued
Submitted on 19 Apr 2023
First Gazette notice for compulsory strike-off
Submitted on 4 Apr 2023
Confirmation statement made on 8 November 2022 with no updates
Submitted on 22 Nov 2022
Accounts for a small company made up to 31 January 2021
Submitted on 1 Feb 2022
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year